Mammalian cells engineered to produce longer-lived versions of therapeutic protein erythropoietin
Erythropoietin (EPO)—a key regulator of red blood cell production—is widely used for treating certain cancers and anemia induced by chronic kidney disease. However, the time that EPO resides in the bloodstream depends ...